122 Views
A new study has revealed the potential of a new experimental cancer drug to slow down inflammation associated with heart disease. The drug, AG-221, was studied in a small-scale clinical trial to determine its effect in controlling inflammation in the arteries of the heart, which can lead to serious cardiovascular complications. The results showed promising results and researchers suggest that this drug could provide a new treatment option for people suffering from heart disease.
https://bazarbiblio.com/experimental-cancer-drug-slow-inflammation-associated-to-heart-disease-study-et-healthworld/
#HeartDisease #CancerDrug #Inflammation #AG221
